Significant differences among patients with relapsing-remitting multiple sclerosis treated with natalizumab and patients with relapsing-remitting multiple sclerosis treated with fingolimod in the included observational study protocols and reported methods for confounders adjustment.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
https://figshare.com/articles/dataset/Significant_differences_among_patients_with_relapsing-remitting_multiple_sclerosis_treated_with_natalizumab_and_patients_with_relapsing-remitting_multiple_sclerosis_treated_with_fingolimod_in_the_included_observational_study_protocols_and_reported_methods/3973077数据链接链接失效反馈
官方服务：
资源简介：
Significant differences among patients with relapsing-remitting multiple sclerosis treated with natalizumab and patients with relapsing-remitting multiple sclerosis treated with fingolimod in the included observational study protocols and reported methods for confounders adjustment.
创建时间：
2016-09-30
